实体肿瘤相关危及生命并发症的紧急化疗
这项多中心回顾性研究(2001-2015年)纳入136例因实体肿瘤相关器官衰竭在ICU接受紧急化疗的成人患者。急性呼吸衰竭是最常见的入ICU原因(111例,81.6%),其中89例需要侵入性机械通气。肿瘤压迫(78例,57.4%)和组织浸润(47例,34.6%)是导致器官受累的主要机制。ICU内、院内、6个月和1年死亡率分别为37%、58%、74%和88%。小细胞肺癌被确定为医院生存的独立预测因素,但1年生存率在小细胞肺癌、非小细胞肺癌和非肺癌患者中均降至20%以下。
要点
- 136例实体肿瘤相关器官衰竭的ICU成人患者接受紧急化疗,ICU内死亡率37%,院内死亡率58%。
- 急性呼吸衰竭是最常见入ICU原因(111例,81.6%),其中89例需要侵入性机械通气。
- 肿瘤压迫(78例,57.4%)和组织浸润(47例,34.6%)是导致器官受累的主要机制。
- 小细胞肺癌是医院生存的独立预测因素,但1年生存率在小细胞肺癌、非小细胞肺癌和非肺癌患者中均降至20%以下。
- 6个月和1年死亡率分别为74%和88%,长期生存难以持续。
适用人群与场景
- 成人患者,因实体肿瘤相关器官衰竭在ICU接受紧急化疗。
- 研究场景为内科和呼吸ICU。
处置流程与药物剂量
- 紧急化疗,联合必要的器械或外科操作及高级生命支持。
研究设计与关键结果
- 多中心回顾性图表审查(2001-2015年),纳入136例患者。
- 肺癌最常见,其中小细胞肺癌57例,非小细胞肺癌33例。
- 急性呼吸衰竭111例(81.6%),其中89例需要侵入性机械通气。
- 肿瘤压迫78例(57.4%),组织浸润47例(34.6%)。
- ICU内、院内、6个月和1年死亡率分别为37%、58%、74%和88%。
- 小细胞肺癌是医院生存的独立预测因素,但1年生存率在小细胞肺癌、非小细胞肺癌和非肺癌患者中均降至20%以下。
证据类型、等级与局限
- 证据类型:多中心回顾性图表审查。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于经过选择的实体肿瘤患者,紧急化疗联合ICU器官衰竭的积极管理可能挽救生命,尤其是小细胞肺癌患者,但长期生存难以持续。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Solid neoplasms can be directly responsible for organ failures at the time of diagnosis or relapse. The management of such specific complications relies on urgent chemotherapy and eventual instrumental or surgical procedures, combined with advanced life support. We conducted a multicenter study to address the prognosis of this condition.
DESIGN: A multicenter retrospective (2001-2015) chart review.
SETTING: Medical and respiratory ICUs.
PATIENTS: Adult patients who received urgent chemotherapy in the ICU for organ failure related to solid neoplasms were included. The modalities of chemotherapy, requirements of adjuvant instrumental or surgical procedures, and organ supports were collected. Endpoints were short- and long-term survival rates.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: One hundred thirty-six patients were included. Lung cancer was the most common malignancy distributed into small cell lung cancer (n = 57) and non-small cell lung cancer (n = 33). The main reason for ICU admission was acute respiratory failure in 111 patients (81.6%), of whom 89 required invasive mechanical ventilation. Compression and tissue infiltration by tumor cells were the leading mechanisms resulting in organ involvement in 78 (57.4%) and 47 (34.6%) patients. The overall in-ICU, in-hospital, 6-month, and 1-year mortality rates were 37%, 58%, 74%, and 88%, respectively. Small cell lung cancer was identified as an independent predictor of hospital survival. However, this gain in survival was not sustained since the 1-year survival rates of small cell lung cancer, non-small cell lung cancer, and non-lung cancer patients all dropped below 20%.
CONCLUSIONS: Urgent chemotherapy along with aggressive management of organ failures in the ICU can be lifesaving in very selected cancer patients, most especially with small cell lung cancer, although the long-term survival is hardly sustainable.
参考来源
- Zerbib Y, Rabbat A, Fartoukh M, et al. Urgent Chemotherapy for Life-Threatening Complications Related to Solid Neoplasms. Crit Care Med. 2017. PMID: 28398925. doi:10.1097/CCM.0000000000002331
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。